Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population
- PMID: 9489916
- DOI: 10.1080/00365529850166284
Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population
Abstract
Background: The relative frequencies of the autoimmune liver diseases primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH) have not been studied. We therefore performed an epidemiologic investigation to describe the incidence and prevalence of the three diseases in a defined population.
Methods: Patients with PBC, PSC, or AIH admitted to Aker University Hospital in Oslo were prospectively registered during the 10-year period 1986-95. This hospital serves a defined population of 130,000 inhabitants. The mean yearly incidence and the point prevalences at the end of each year were calculated.
Results: During the 10-year period 21 patients with PBC, 17 with PSC, and 25 with AIH were diagnosed. The mean annual incidence per 100,000 was 1.6 for PBC, 1.3 for PSC, and 1.9 for AIH. The point prevalences per 100,000 on 31 December 1995 were 14.6, 8.5, and 16.9 for PBC, PSC, and AIH, respectively.
Conclusions: The prevalences of PBC and AIH are of the same order of magnitude and about twice as high as that of PSC. These epidemiologic data can be used to estimate the number of liver transplantations required due to autoimmune liver diseases.
Similar articles
-
[Autoimmune liver diseases and their overlap syndromes].Praxis (Bern 1994). 2006 Sep 6;95(36):1363-81. doi: 10.1024/1661-8157.95.36.1363. Praxis (Bern 1994). 2006. PMID: 16989180 Review. German.
-
Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.Clin Gastroenterol Hepatol. 2018 Feb;16(2):278-287.e7. doi: 10.1016/j.cgh.2017.09.062. Epub 2017 Oct 6. Clin Gastroenterol Hepatol. 2018. PMID: 28993258
-
Diagnosis and management of overlap syndromes.Clin Liver Dis. 2015 Feb;19(1):81-97. doi: 10.1016/j.cld.2014.09.005. Epub 2014 Nov 21. Clin Liver Dis. 2015. PMID: 25454298 Review.
-
[Incidence and prevalence of autoimmune liver diseases].Tidsskr Nor Laegeforen. 1998 Nov 30;118(29):4517-9. Tidsskr Nor Laegeforen. 1998. PMID: 9889636 Norwegian.
-
Epidemiology of autoimmune liver disease.J Gastroenterol Hepatol. 2003 Oct;18(10):1118-28. doi: 10.1046/j.1440-1746.2003.03165.x. J Gastroenterol Hepatol. 2003. PMID: 12974897 Review.
Cited by
-
A nationwide population-based prospective study of cirrhosis in Iceland.JHEP Rep. 2021 Mar 31;3(3):100282. doi: 10.1016/j.jhepr.2021.100282. eCollection 2021 Jun. JHEP Rep. 2021. PMID: 34041467 Free PMC article.
-
Primary sclerosing cholangitis: diagnosis and management.Curr Gastroenterol Rep. 2006 Feb;8(1):75-82. doi: 10.1007/s11894-006-0067-8. Curr Gastroenterol Rep. 2006. PMID: 16510038 Review.
-
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice.J Pers Med. 2022 Jun 2;12(6):925. doi: 10.3390/jpm12060925. J Pers Med. 2022. PMID: 35743710 Free PMC article. Review.
-
Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population.Can J Gastroenterol Hepatol. 2021 Nov 10;2021:7746401. doi: 10.1155/2021/7746401. eCollection 2021. Can J Gastroenterol Hepatol. 2021. PMID: 34805028 Free PMC article.
-
Autoimmune hepatitis.Nat Rev Gastroenterol Hepatol. 2011 Jun;8(6):320-9. doi: 10.1038/nrgastro.2011.69. Epub 2011 May 3. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21537351 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources